|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Trevi Therapeutics Inc. (TRVI)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-05-09 Purchase |
2019-05-13 6:06 pm |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
800,000 | $10 | $8,000,000 | 6,573,000 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:15 pm |
Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:15 pm |
Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:14 pm |
Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:14 pm |
Trevi Therapeutics Inc. | TRVI | MOTT DAVID M 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:13 pm |
Trevi Therapeutics Inc. | TRVI | MAKOWER JOSHUA 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:13 pm |
Trevi Therapeutics Inc. | TRVI | Makhzoumi Mohamad 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:12 pm |
Trevi Therapeutics Inc. | TRVI | Florence Anthony A. Jr. 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:12 pm |
Trevi Therapeutics Inc. | TRVI | Chang Carmen 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:11 pm |
Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:11 pm |
Trevi Therapeutics Inc. | TRVI | BASKETT FOREST 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:11 pm |
Trevi Therapeutics Inc. | TRVI | BARRIS PETER J 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:10 pm |
Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
2,500,000 | $10 | $25,000,000 | 4,438,562 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:03 pm |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
11,250 | $10 | $112,500 | 352,489 (Direct Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:03 pm |
Trevi Therapeutics Inc. | TRVI | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Mitsak Anna Guyer 10% Owner |
481,000 | $10 | $4,810,000 | 1,063,408 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:03 pm |
Trevi Therapeutics Inc. | TRVI | Mellon Family Investment Co V MFIC V LLC 10% Owner |
100,000 | $10 | $1,000,000 | 347,156 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:01 pm |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
2,500 | $10 | $25,000 | 6,351 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:01 pm |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L Director, 10% Owner |
11,250 | $10 | $112,500 | 206,204 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:01 pm |
Trevi Therapeutics Inc. | TRVI | Aperture Venture Partners IV L.P. Aperture Ventures IV Management LLC 10% Owner |
112,000 | $10 | $1,120,000 | 344,963 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:01 pm |
Trevi Therapeutics Inc. | TRVI | Agger Mette Kirstine Director |
375,000 | $10 | $3,750,000 | 1,151,544 (Indirect) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:00 pm |
Trevi Therapeutics Inc. | TRVI | Richard King Mellon Foundation 10% Owner |
100,000 | $10 | $1,000,000 | 347,157 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:00 pm |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
5,000 | $10 | $50,000 | 25,983 (Direct) |
View |
| 2019-05-09 Purchase |
2019-05-13 5:00 pm |
Trevi Therapeutics Inc. | TRVI | Lundbeckfond Invest A/S 10% Owner |
375,000 | $10 | $3,750,000 | 1,151,544 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-03 Option Award |
2019-06-05 5:11 pm |
N/A 2029-06-02 |
Trevi Therapeutics Inc. | TRVI | Seiter Christopher CFO |
50,000 | $10.12 | 50,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 5:09 pm |
N/A 2029-06-02 |
Trevi Therapeutics Inc. | TRVI | Muscolo Frank P Controller |
15,000 | $10.12 | 15,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 5:08 pm |
N/A 2029-06-02 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
50,000 | $10.12 | 50,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 5:07 pm |
N/A 2029-06-02 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L CEO |
310,000 | $10.12 | 310,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 5:04 pm |
N/A 2029-06-02 |
Trevi Therapeutics Inc. | TRVI | Mazabraud Yann See Remarks |
50,000 | $10.12 | 50,000 (Direct) |
View |
| 2019-06-01 Exercise |
2019-06-04 4:31 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
200,000 | $0 | 6,324,319 (Indirect) |
View |
| 2019-06-01 Exercise |
2019-06-04 4:31 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
1 | $0 | 6,324,319 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 6:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
5,773,000 | $0 | 6,573,000 (Indirect) |
View |
| 2019-05-09 Other |
2019-05-13 6:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
48,681 | $0 | 6,573,000 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 6:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
13,164,257 | $0 | 6,573,000 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 6:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
21,739,130 | $0 | 6,573,000 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 6:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
8,243,948 | $0 | 6,573,000 (Indirect) |
View |
| 2019-05-09 Other |
2019-05-13 6:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
1 | $0 | 6,573,000 (Indirect) |
View |
| 2019-05-09 Other |
2019-05-13 6:06 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
1 | $0 | 6,573,000 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:15 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:15 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Walker Paul Edward 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:15 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:15 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Sonsini Peter W. 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:14 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:14 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SANDELL SCOTT D 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:14 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | MOTT DAVID M 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:14 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | MOTT DAVID M 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:13 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | MAKOWER JOSHUA 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:13 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | MAKOWER JOSHUA 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:13 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Makhzoumi Mohamad 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:13 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Makhzoumi Mohamad 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:12 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Florence Anthony A. Jr. 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:12 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Florence Anthony A. Jr. 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:12 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Chang Carmen 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:12 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Chang Carmen 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:11 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:11 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:11 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | BASKETT FOREST 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:11 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | BASKETT FOREST 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:11 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | BARRIS PETER J 10% Owner |
1,938,562 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:11 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | BARRIS PETER J 10% Owner |
17,099,316 | $0 | 4,438,562 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:10 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
1,938,562 | $0 | 4,438,562 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:10 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
17,099,316 | $0 | 4,438,562 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:04 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | DRAKE PETER F 10% Owner |
62,540 | $0 | 62,540 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:04 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | DRAKE PETER F 10% Owner |
133,153 | $0 | 62,540 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:04 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | DRAKE PETER F 10% Owner |
376,023 | $0 | 62,540 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
300,536 | $0 | 352,489 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
27,432 | $0 | 352,489 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
13,271 | $0 | 352,489 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
924,880 | $0 | 352,489 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
192,000 | $0 | 352,489 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
95,712 | $0 | 352,489 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
869,565 | $0 | 352,489 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
478,951 | $0 | 352,489 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Mitsak Anna Guyer 10% Owner |
582,408 | $0 | 1,063,408 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Mitsak Anna Guyer 10% Owner |
5,136,986 | $0 | 1,063,408 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Mellon Family Investment Co V MFIC V LLC 10% Owner |
222,816 | $0 | 347,156 (Direct) |
View |
| 2019-05-09 Other |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Mellon Family Investment Co V MFIC V LLC 10% Owner |
24,340 | $0 | 347,156 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:03 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Mellon Family Investment Co V MFIC V LLC 10% Owner |
1,908,450 | $0 | 347,156 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:02 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | OSHEA WILLIAM J 10% Owner |
99,046 | $0 | 114,080 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:02 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | OSHEA WILLIAM J 10% Owner |
307,607 | $0 | 114,080 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:02 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | OSHEA WILLIAM J 10% Owner |
478,951 | $0 | 114,080 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
3,851 | $0 | 6,351 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
34,247 | $0 | 6,351 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L Director, 10% Owner |
18,348 | $0 | 206,204 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L Director, 10% Owner |
109,015 | $0 | 206,204 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L Director, 10% Owner |
23,947 | $0 | 206,204 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Aperture Venture Partners IV L.P. Aperture Ventures IV Management LLC 10% Owner |
232,963 | $0 | 344,963 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Aperture Venture Partners IV L.P. Aperture Ventures IV Management LLC 10% Owner |
2,054,795 | $0 | 344,963 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Agger Mette Kirstine Director |
776,544 | $0 | 1,151,544 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Agger Mette Kirstine Director |
6,849,315 | $0 | 1,151,544 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Richard King Mellon Foundation 10% Owner |
222,816 | $0 | 347,157 (Direct) |
View |
| 2019-05-09 Other |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Richard King Mellon Foundation 10% Owner |
24,341 | $0 | 347,157 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Richard King Mellon Foundation 10% Owner |
1,908,450 | $0 | 347,157 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
20,983 | $0 | 25,983 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
107,977 | $0 | 25,983 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
47,807 | $0 | 25,983 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Lundbeckfond Invest A/S 10% Owner |
776,544 | $0 | 1,151,544 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Lundbeckfond Invest A/S 10% Owner |
6,849,315 | $0 | 1,151,544 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Drake Debra A 10% Owner |
52,141 | $0 | 52,141 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Drake Debra A 10% Owner |
10,399 | $0 | 52,141 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Drake Debra A 10% Owner |
58,153 | $0 | 52,141 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Drake Debra A 10% Owner |
75,000 | $0 | 52,141 (Indirect) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Drake Debra A 10% Owner |
376,023 | $0 | 52,141 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer, 10% Owner |
17,118 | $0 | 193,724 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer, 10% Owner |
109,015 | $0 | 193,724 (Direct) |
View |
| 2019-05-09 Conversion |
2019-05-13 5:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer, 10% Owner |
13,410 | $0 | 193,724 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-08 5:22 pm |
N/A 2029-05-06 |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
23,684 | $10 | 23,684 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-08 5:01 pm |
N/A 2029-05-06 |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
23,684 | $10 | 23,684 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-08 5:00 pm |
N/A 2029-05-06 |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director, 10% Owner |
23,684 | $10 | 23,684 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-08 5:00 pm |
N/A 2029-05-06 |
Trevi Therapeutics Inc. | TRVI | Mitsak Anna Guyer Director |
23,684 | $10 | 23,684 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-08 5:00 pm |
N/A 2029-05-06 |
Trevi Therapeutics Inc. | TRVI | Nadav Eran Director |
23,684 | $10 | 23,684 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-08 5:00 pm |
N/A 2029-05-06 |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
23,684 | $10 | 23,684 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-08 5:00 pm |
N/A 2029-05-06 |
Trevi Therapeutics Inc. | TRVI | Agger Mette Kirstine Director |
23,684 | $10 | 23,684 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 13 Nov 2019 02:03:42 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |